Submitted by Anonymous (not verified) on 9 April 2026 - 14:08
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Fintepla, fenfluramine, Date of authorisation: 18/12/2020, Revision: 16, Status: Authorised